These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37158225)

  • 1. Clinical utility of somatostatin receptor positron emission tomography imaging biomarkers for characterization of meningioma among incidental central nervous system lesions.
    Ensign SF; Agarwal M; Klanderman M; Badawy M; Halfdanarson TR; Johnson DR; Sonbol MB; Kendi AT
    Nucl Med Commun; 2023 Jul; 44(7):663-670. PubMed ID: 37158225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semi-automated segmentation methods of SSTR PET for dosimetry prediction in refractory meningioma patients treated by SSTR-targeted peptide receptor radionuclide therapy.
    Boursier C; Zaragori T; Bros M; Bordonne M; Melki S; Taillandier L; Blonski M; Roch V; Marie PY; Karcher G; Imbert L; Verger A
    Eur Radiol; 2023 Oct; 33(10):7089-7098. PubMed ID: 37148355
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Kowalski ES; Khairnar R; Gryaznov AA; Kesari V; Koroulakis A; Raghavan P; Chen W; Woodworth G; Mishra M
    Radiat Oncol; 2021 Aug; 16(1):151. PubMed ID: 34399805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of incidental brain uptake on 68Ga-DOTATATE PET-CT in neuroendocrine tumour patients.
    Cleary JO; Yeung J; McMeekin H; Wilhelm T; Wagner T
    Nucl Med Commun; 2016 Nov; 37(11):1197-205. PubMed ID: 27399848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gallium-68 DOTATATE PET in the Evaluation of Intracranial Meningiomas.
    Ivanidze J; Roytman M; Lin E; Magge RS; Pisapia DJ; Liechty B; Karakatsanis N; Ramakrishna R; Knisely J; Schwartz TH; Osborne JR; Pannullo SC
    J Neuroimaging; 2019 Sep; 29(5):650-656. PubMed ID: 31107591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating diagnostic accuracy and determining optimal diagnostic thresholds of different approaches to [
    Kim SH; Roytman M; Madera G; Magge RS; Liechty B; Ramakrishna R; Pannullo SC; Schwartz TH; Karakatsanis NA; Osborne JR; Lin E; Knisely JPS; Ivanidze J
    Sci Rep; 2022 Jun; 12(1):9256. PubMed ID: 35661809
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Pauwels E; Cleeren F; Tshibangu T; Koole M; Serdons K; Boeckxstaens L; Dekervel J; Vandamme T; Lybaert W; den Broeck BV; Laenen A; Clement PM; Geboes K; Cutsem EV; Stroobants S; Verslype C; Bormans G; Deroose CM
    J Nucl Med; 2023 Apr; 64(4):632-638. PubMed ID: 36265911
    [No Abstract]   [Full Text] [Related]  

  • 8.
    Hope TA; Calais J; Zhang L; Dieckmann W; Millo C
    J Nucl Med; 2019 Sep; 60(9):1266-1269. PubMed ID: 30850506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin receptor imaging in non-(131)I-avid metastatic differentiated thyroid carcinoma for determining the feasibility of peptide receptor radionuclide therapy with (177)Lu-DOTATATE: low fraction of patients suitable for peptide receptor radionuclide therapy and evidence of chromogranin A level-positive neuroendocrine differentiation.
    Jois B; Asopa R; Basu S
    Clin Nucl Med; 2014 Jun; 39(6):505-10. PubMed ID: 24662668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 68 Ga-DOTATATE PET to Characterize Lesions in the Neuroaxis.
    Hartmann K; Gillman JA; Lazor JW; Ware JB; Weeks JK; Nasrallah IM; Farwell MD; Pantel AR
    Clin Nucl Med; 2024 Jan; 49(1):9-15. PubMed ID: 38048554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Prospective Registry Study of
    Perlow HK; Nalin AP; Handley D; Gokun Y; Blakaj DM; Beyer SJ; Thomas EM; Raval RR; Boulter D; Kleefisch C; Bovi J; Chen WC; Braunstein SE; Raleigh DR; Knisely JPS; Ivanidze J; Palmer JD
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(4):979-985. PubMed ID: 37871886
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Perlow HK; Siedow M; Gokun Y; McElroy J; Matsui J; Zoller W; Beyer S; Arnett A; Blakaj D; Boulter D; Fritz J; Miller E; Raval R; Kleefisch C; Bovi J; Palmer JD
    Int J Radiat Oncol Biol Phys; 2022 Jul; 113(4):859-865. PubMed ID: 35460804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue.
    Rachinger W; Stoecklein VM; Terpolilli NA; Haug AR; Ertl L; Pöschl J; Schüller U; Schichor C; Thon N; Tonn JC
    J Nucl Med; 2015 Mar; 56(3):347-53. PubMed ID: 25635133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma.
    Kurz SC; Zan E; Cordova C; Troxel AB; Barbaro M; Silverman JS; Snuderl M; Zagzag D; Kondziolka D; Golfinos JG; Chi AS; Sulman EP
    Clin Cancer Res; 2024 Feb; 30(4):680-686. PubMed ID: 38048045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Brain Incidental Lesions Detected by
    Albano D; Treglia G; Dondi F; Bertagna F
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888635
    [No Abstract]   [Full Text] [Related]  

  • 16. Discordance Between Histopathologic Grading and Dual-Tracer PET/CT Findings in Metastatic NETs and Outcome of
    Adnan A; Basu S
    J Nucl Med Technol; 2022 Sep; 50(3):248-255. PubMed ID: 34876476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome prediction of SSTR-RADS-3A and SSTR-RADS-3B lesions in patients with neuroendocrine tumors based on
    Gao J; Zhou J; Liu C; Pan Y; Lin X; Zhang Y
    J Cancer Res Clin Oncol; 2024 May; 150(5):272. PubMed ID: 38795250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation and Comparison of Somatostatin Receptor Type 2 Immunohistochemical Scoring Systems with 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms.
    Yu J; Cao F; Zhao X; Xie Q; Lu M; Li J; Yang Z; Sun Y
    Neuroendocrinology; 2022; 112(4):358-369. PubMed ID: 34077939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Clinical Utility of Gallium-68-DOTATATE Positron Emission Tomography Scanning in Medullary Thyroid Cancer.
    Gild ML; Kumar S; Fuchs TL; Glover A; Sidhu S; Sywak M; Tsang V; Gill AJ; Robinson BG; Schembri G; Clifton-Bligh RJ; Hoang J
    Endocr Pract; 2024 Mar; 30(3):218-224. PubMed ID: 38103829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin Receptor-PET/CT/MRI of Head and Neck Neuroendocrine Tumors.
    Rini JN; Keir G; Caravella C; Goenka A; Franceschi AM
    AJNR Am J Neuroradiol; 2023 Aug; 44(8):959-966. PubMed ID: 37442593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.